Perasso A, Testino G
Divisione di Gastroenterologia ed Endoscopia Digestiva, Ospedale San Martino, Genova.
Recenti Prog Med. 1993 Feb;84(2):106-17.
The interferon therapy has represented a breakthrough in the treatment of chronic hepatitis. In this article we analyzed the results of short- and long-term therapy of hepatitis C, particularly referred to different dosage regimens and side effects. We paid particular attention to patients non responders to interferon therapy, for whom we reported the results obtained with the association of interferon and ursodeoxycholic acid, and with steroidal treatment.
干扰素疗法在慢性肝炎治疗方面取得了突破。在本文中,我们分析了丙型肝炎短期和长期治疗的结果,尤其涉及不同的剂量方案和副作用。我们特别关注对干扰素治疗无反应的患者,为此报告了干扰素与熊去氧胆酸联合使用以及甾体治疗所取得的结果。